These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29950852)

  • 1. Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.
    Shunmoogam N; Naidoo P; Chilton R
    Vasc Health Risk Manag; 2018; 14():137-143. PubMed ID: 29950852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of paraoxonases: a brief review.
    Draganov DI; La Du BN
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
    Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
    JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
    Mackness MI; Durrington PN; Mackness B
    Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
    Kim DS; Marsillach J; Furlong CE; Jarvik GP
    Pharmacogenomics; 2013 Sep; 14(12):1495-515. PubMed ID: 24024900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PON1 lactonase activity and its association with cardiovascular disease.
    Murillo-González FE; Ponce-Ruiz N; Rojas-García AE; Rothenberg SJ; Bernal-Hernández YY; Cerda-Flores RM; Mackness M; Barrón-Vivanco BS; González-Arias CA; Ponce-Gallegos J; Medina-Díaz IM
    Clin Chim Acta; 2020 Jan; 500():47-53. PubMed ID: 31626760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does paraoxonase play a role in susceptibility to cardiovascular disease?
    Aviram M
    Mol Med Today; 1999 Sep; 5(9):381-6. PubMed ID: 10462749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?
    Davis KA; Crow JA; Chambers HW; Meek EC; Chambers JE
    Environ Health Perspect; 2009 Aug; 117(8):1226-31. PubMed ID: 19672401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
    Tang WH; Hartiala J; Fan Y; Wu Y; Stewart AF; Erdmann J; Kathiresan S; ; Roberts R; McPherson R; Allayee H; Hazen SL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2803-12. PubMed ID: 22982463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growing importance of PON1 in cardiovascular health: a review.
    Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.
    Zargari M; Sharafeddin F; Mahrooz A; Alizadeh A; Masoumi P
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1489-96. PubMed ID: 27022137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.
    Connelly PW; Zinman B; Maguire GF; Mamakeesick M; Harris SB; Hegele RA; Retnakaran R; Hanley AJ
    J Lipid Res; 2009 Jun; 50(6):1216-22. PubMed ID: 19151417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
    Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
    Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
    Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
    Nus M; Frances F; Librelotto J; Canales A; Corella D; Sánchez-Montero JM; Sánchez-Muniz FJ
    J Nutr; 2007 Jul; 137(7):1783-8. PubMed ID: 17585031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.
    Grubisa I; Otasević P; Dimković N; Nedeljković I; Toljić B; Vucinić N
    Srp Arh Celok Lek; 2013; 141(9-10):629-33. PubMed ID: 24364225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.